NCT01222780
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Tumors, +40 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,084 public trials
2,045 recruiting studies
Lymphoproliferative Disorders trial results
NCT00078858
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
- Locations
-
- Stanford University Hospitals and Clinics Stanford, California, United States
- Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT00166439
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01239875
- Conditions
- Adult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis, +37 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00651937
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Allo-hNHL (FluBuCy)
NCT00785330
- Conditions
- Disease Attributes, Graft vs Host Disease, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Universitätsklinikum Heidelberg Heidelberg, Baden-Würtenberg, Germany
- Universitätsklinikum Marburg Marburg, Hesse, Germany
- Universitätsklinikum und Poliklinik Homburg, Saarland, Germany
- University Hospital Goettingen Göttingen, Germany
NCT02567656
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope Duarte, California, United States
- Chao Family Comprehensive Cancer Center University of California Irvine Orange, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Emory University School of Medicine Atlanta, Georgia, United States
Completed
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
NCT00490529
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
NCT01110733
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- DCH Cancer Treatment Center Tuscaloosa, Alabama, United States
- Arizona Cancer Center Tucson, Arizona, United States
- Genesis Cancer Center Hot Springs, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT01059630
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Southern Cancer Center, PC Mobile, Alabama, United States
- Dr. Donald W. Hill, MD, FACP Casa Grande, Arizona, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- Kaiser Permanente - Bellflower Bellflower, California, United States